SCI TOP 10

当前位置:首页>SCI TOP 10

肌成纤维细胞的分化:眼部伤口愈合和纤维化的黑马

Shu, D.Y., Lovicu, F.J.

期刊名称:Progress in Retinal and Eye Research

卷期:2017年第60卷

关键词:
眼部 黑马 纤维

摘要

摘要:伤口愈合是生命中最复杂的生物过程之一。损伤后组织的修复涉及多种细胞类型,生长因子,炎性介质和细胞外基质(ECM)组分之间的动态相互作用。异常和不受控制的伤口愈合可导致纤维组织的非功能性团块形成。在眼中,纤维化疾病会破坏正常透明的眼组织,导致不可逆转的视力丧失。纤维化眼疾病的一个共同特征是细胞转化成肌成纤维细胞,这可以通过上皮 - 间质转化(EMT)的过程发生。肌成纤维细胞快速产生过量的ECM,并在ECM上施加牵拉力,导致组织结构变形。转化生长因子-β(TGFβ)在肌成纤维细胞转分化中起主要作用,并且涉及许多纤维化眼疾病,包括角膜混浊,翼状胬肉,前囊下性白内障,后囊膜混浊,增生性玻璃体视网膜病变,与增生性糖尿病视网膜病变有关的纤维血管膜形成,黄斑下纤维化,青光眼和眼眶纤维化。该综述介绍了肌成纤维母细胞在纤维化眼病中的病理功能。我们还强调了纤维形成过程中涉及的多重信号途径的最新进展,这些途径可能用于研发新的抗纤维化疗法以减少瘢痕形成导致的眼部发病率。

Wound healing is one of the most complex biological processes to occur in life. Repair of tissue following injury involves dynamic interactions between multiple cell types, growth factors, inflammatory mediators and components of the extracellular matrix (ECM). Aberrant and uncontrolled wound healing leads to a non-functional mass of fibrotic tissue. In the eye, fibrotic disease disrupts the normally transparent ocular tissues resulting in irreversible loss of vision. A common feature in fibrotic eye disease is the transdifferentiation of cells into myofibroblasts that can occur through a process known as epithelial-mesenchymal transition (EMT). Myofibroblasts rapidly produce excessive amounts of ECM and exert tractional forces across the ECM, resulting in the distortion of tissue architecture. Transforming growth factor-beta (TGFβ) plays a major role in myofibroblast transdifferentiation and has been implicated in numerous fibrotic eye diseases including corneal opacification, pterygium, anterior subcapsular cataract, posterior capsular opacification, proliferative vitreoretinopathy, fibrovascular membrane formation associated with proliferative diabetic retinopathy, submacular fibrosis, glaucoma and orbital fibrosis. This review serves to introduce the pathological functions of the myofibroblast in fibrotic eye disease. We also highlight recent developments in elucidating the multiple signaling pathways involved in fibrogenesis that may be exploited in the development of novel anti-fibrotic therapies to reduce ocular morbidity due to scarring.


点击下载

CopyRight 2016  兴齐100版权所有 京ICP证060955号
技术支持:示剑网络   http://100.sinqi.com/